RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
Acologix Inc Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment. Series C USD 25,300,000
Acologix Inc Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment. Series B USD 40,000,000

BEST FUNDED


Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment.

Clinical stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide